CRSP
Price
$53.39
Change
+$2.95 (+5.85%)
Updated
Oct 9 closing price
Capitalization
5.23B
24 days until earnings call
Intraday BUY SELL Signals
IBB
Price
$206.49
Change
+$6.01 (+3.00%)
Updated
Oct 9 closing price
Net Assets
10.41B
Intraday BUY SELL Signals
Interact to see
Advertisement

CRSP vs IBB

CRSP vs IBB Comparison Chart in %
View a ticker or compare two or three
VS
CRSP vs. IBB commentary
Oct 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and IBB is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPIBB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 6 days ago
90%
COMPARISON
Comparison
Oct 11, 2026
Stock price -- (CRSP: $53.39)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green while .

  • CRSP’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish.

  • CRSP’s TA Score: 4 bullish, 6 bearish.

Price Growth

CRSP (@Biotechnology) experienced а -3.68% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.51%. For the same industry, the average monthly price growth was -13.43%, and the average quarterly price growth was -4.26%.

Reported Earning Dates

CRSP is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (-2.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CRSP
Daily Signal:
Gain/Loss:
IBB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GRNY28.450.21
+0.74%
Fundstrat Granny Shots US Large Cap ETF
PSCQ32.580.11
+0.35%
Pacer Swan SOS Conservative (October) ETF (PSCQ)
GRX9.630.03
+0.31%
Gabelli Healthcare & Wellness Trust (The)
BBBL43.85-0.03
-0.08%
BondBloxx BBB Rated 10+ Year Corporate Bond ETF (BBBL)
TNGY11.33-0.03
-0.26%
Tortoise Energy ETF (TNGY)

IBB and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBB has been closely correlated with VRTX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if IBB jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBB
1D Price
Change %
IBB100%
+3.00%
VRTX - IBB
67%
Closely correlated
+1.36%
CRSP - IBB
63%
Loosely correlated
+5.85%
AMGN - IBB
61%
Loosely correlated
+1.82%
EDIT - IBB
60%
Loosely correlated
+2.11%
BEAM - IBB
58%
Loosely correlated
+4.47%
More